Clinical trial
Stress, Diurnal Cortisol, and Breast Cancer Survival
NCT00226967 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00226967 |
|---|---|
| Title | Stress, Diurnal Cortisol, and Breast Cancer Survival |
| Official title | Stress, Diurnal Cortisol, and Breast Cancer Survival |
| Lead sponsor | Stanford University, Other |
| Collaborators | National Institute on Aging (NIA) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Sandostatin |
| Enrollment | 115 |
| Start date | Sep 8, 2002 |
| Primary completion | Nov 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Sep 27, 2005 |
| Last update posted | Jan 27, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: